Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Ali, Ogul"'
Autor:
Cem MIRILI, Semra PAYDAS, Mahmut BUYUKSIMSEK, Mert TOHUMCUOĞLU, Abdullah Evren YETISIR, Ali OGUL
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 7, Iss 3, Pp 271-278 (2019)
Aim:fSoft tissue sarcomas (STSs) account for 1% of cancers in the adult population. The treatment of choice is surgery but chemotherapy and/or radiotherapy are frequently used due to aggressive cancer behavior or incomplete surgery. Doxorubicin-based
Externí odkaz:
https://doaj.org/article/23346dd820e14da8beb87db1e8c11283
Autor:
Cem Mirili, Semra Paydas, Ali Ogul, Serkan Gokcay, Mahmut Buyuksimsek, Evren Yetisir, Ismail Hanta, Melek Ergin, Emine Bağır Kılıç, Isa Burak Guney
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 56-59 (2018)
Marginal zone lymphoma (MZL) is low grade lymphoma and accounts about 5% of all lymphomas and 5–10% of MZLs are localized in the lung. Interstitial Lung Disease (ILD) is a group of systemic diseases characterized by diffuse inflammation in lung and
Externí odkaz:
https://doaj.org/article/36f74dd0b02343b3a7751fd52b183291
Autor:
Mahmut Buyuksimsek, Ali Ogul, Abdullah Evren Yetisir, Berna Bozkurt Duman, Mert Tohumcuoglu, Timucin Cil, Tolga Koseci, Mehmet Mutlu Kidi, Hilmi Erdem Sumbul
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311713
Introduction Brigatinib is a next-generation anaplastic lymphoma kinase (ALK) inhibitor that targets a wide variety of ALK mutations and ROS1 rearrangements. While pancreatic enzyme elevations due to brigatinib are well known, we wanted to present a
Autor:
Isa Burak Guney, Mahmut Büyükşimşek, Abdullah Evren Yetisir, Cem Mirili, İrem Kolsuz, Ali Ogul, Semra Paydas, Mert Tohumcuoglu
Publikováno v:
Turkish Journal of Hematology, Vol 37, Iss 4, Pp 220-225 (2020)
Turkish Journal of Hematology
Turkish Journal of Hematology
Bone marrow infiltration (BMI) affects the stage diagnosis, and treatment of lymphoma. We aimed to evaluate the performance of bone marrow biopsy (BMB) and positron emission tomography-computed tomography (PET/CT) in detecting BMI in lymphoma patient
Publikováno v:
Eur J Breast Health
Objective Response to neoadjuvant chemotherapy (NAC) is predictive for survival times in some patients with breast cancer (BC). The aim of this study is to explore the predictive value of some inflammatory markers including neutrophil-to-lymphocyte r
Autor:
Mahmut Büyükşimşek, Ali Ogul
Publikováno v:
Medical Science and Discovery. 7:475-481
Objective: Systemic inflammatory markers have been shown to have prognostic value in many types of cancers. Although the prognostic role of the systemic immune-inflammation index (SII), derived neutrophil-lymphocyte ratio (dNLR) and platelet lymphocy
Autor:
Ali Ogul, Mahmut Buyuksimsek
Publikováno v:
Medical Science and Discovery. 7:459-465
Objective: According to metastatic renal cell carcinoma treatment protocol, after the use of tyrosine kinase inhibitors (TKI) has been achieved significant improvements for the treatment of metastatic renal cell carcinoma (mRCC). In this study, we ai
Autor:
Huseyin Can Arbag, Hilmi Erdem Sumbul, Mahmut Buyuksimsek, Ali Ogul, Abdullah Evren Yetisir, Tolga Koseci, Berna Bozkurt Duman, Mert Tohumcuoglu, Oguzhan Kesen, Timucin Cil
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction The addition of panitumumab to chemotherapy in wild-type metastatic colon cancer contributes to survival. While the skin related side effects of panitumumab are well known, we wanted to present a case where it was a possible cause of acu
Autor:
Ali, Ogul, Semra, Paydas, Figen, Doran, Kivilcim Eren, Erdogan, Mert, Tohumcuoglu, Mahmut, Buyuksimsek, Cem, Mirili, Abdullah Evren, Yetisir
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 26(3)
There are no studies showing PRAME expression in stage II and III colon adenocarcinoma. In this study, we aimed to determine the frequency of PRAME expression and the relationship with survival and clinicopathological data in stage II and III colon a
Autor:
Ibrahim Boga, M Togun, Atil Bisgin, Mahmut Büyükşimşek, Berksoy Sahin, Mert Tohumcuoglu, Yetisir A Evren, Ali Ogul, Sumbul H Erdem, Kara I Oguz, Cem Mirili
Publikováno v:
Balkan Journal of Medical Genetics, Vol 22, Iss 2, Pp 17-24 (2019)
Balkan Journal of Medical Genetics : BJMG
Balkan Journal of Medical Genetics : BJMG
Several studies demonstrated the utility of plasma-based cell-free circulating tumor DNA (ccfDNA) in determination of mutations in non-small cell lung cancer (NSCLC). We aimed to report our results of next generation sequencing (NGS) using liquid bio